The UK Precision Biotics Market was valued at $294.8 Million in 2026 and projected to reach to $508 Million by 2031, representing a compound annual growth rate of 11.5%. The UK precision biotics market is positioned for sustained expansion as healthcare providers and consumers increasingly embrace personalized medicine approaches.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK precision biotics market is valued at $294.8 million in 2026 and is projected to reach $508.0 million by 2031, representing a robust 11.5% CAGR over the forecast period.
UK consumers are increasingly adopting personalized nutrition approaches, with growing recognition of precision biotics' role in optimizing individual health outcomes based on genetic and microbiome profiles.
Rising prevalence of digestive health concerns across the UK population is driving demand for targeted probiotic solutions that address specific gut microbiome imbalances and individual health needs.
The UK's advanced healthcare infrastructure and stringent regulatory framework provide a competitive advantage, ensuring high-quality precision biotic products and fostering consumer trust in the market.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | NEXT-GENERATION PROBIOTICS (Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 13.5% from 2026 to 2031 |
| Largest Segment | HUMAN (End User) |
| Market Size Base Year (Billions) | ~USD 4.92 (2026) |
| Revenue Forecast (Billions) | ~USD 9.26 (2031) |
| Segments Covered | Type, End-Use Industry, Distribution Channel, Health/Functional Positioning, Health & Functional Positioning, Application, Type 2026-2031, Ingredient, End User |
9 segment dimensions are covered across the global market.
| Segment | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|
| NEXT-GENERATION PROBIOTICS | 46 | 52.9 | 60.7 | 69.6 | 79.8 | 91.4 | 14.7 |
| POSTBIOTICS | 38.8 | 43.8 | 49.5 | 56 | 63.2 | 71.4 | 13 |
| PRECISION PROBIOTICS | 157.9 | 173.9 | 191.5 | 210.9 | 232.1 | 255.4 | 10.1 |
| SYNBIOTICS | 52.1 | 58.1 | 64.8 | 72.2 | 80.5 | 89.8 | 11.5 |
| TOTAL | 294.8 | 328.7 | 366.5 | 408.7 | 455.6 | 508 | 11.5 |
The UK precision biotics market is valued at $294.8 million in 2026 and is expected to grow to $508.0 million by 2031.
The UK precision biotics market is growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2031.
The UK market is driven by increasing consumer awareness of personalized nutrition, rising digestive health concerns, strong regulatory frameworks, and significant biotechnology R&D investment.
The UK precision biotics market is distributed through established retail partnerships, e-commerce platforms, and healthcare channels, leveraging the country's advanced distribution infrastructure.
The UK precision biotics market is forecast to reach $508.0 million by 2031, growing from $294.8 million in 2026 at an 11.5% CAGR.
This study employed two primary approaches to estimate the current size of the precision biotics market. Exhaustive secondary research was carried out to collect information on the precision biotics type, end-user industry, health/functional positioning, distribution channel, and region. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.
This research study used extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, agriculture and precision biotics-related journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.
Extensive primary research was conducted after obtaining information regarding the precision biotics market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides. Primary data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as chief experience officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, and related key executives from distributors and key opinion leaders.
Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to precision biotics type, end-use industry, health/functional positioning, distribution channel, and region. Stakeholders from the demand side, including consumers, healthcare professionals, gastroenterologists, dietitians, nutritionists, functional medicine practitioners, hospitals and specialty clinics, pharmacies, e-commerce retailers, health & wellness retailers, and personalized nutrition platforms, were interviewed to understand buyers' perspectives on product efficacy, brand preferences, purchasing behavior, distribution channels, pricing trends, and the future outlook of the precision biotics market.
Breakdown of Primary Interviews

Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue >USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue <USD 100 million.
|
COMPANY |
DESIGNATION |
|
BioGaia (Sweden) |
Regional Sales Manager |
|
Pendulum (US) |
Marketing Manager |
|
Seed Health, Inc (US) |
General Manager |
|
Infinant Health Inc (US) |
Sales Manager |
|
thegoodbug (India) |
Sales Manager |
|
Symrise (Germany)- (Probi) |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches were used to estimate and validate the total size of the precision biotics market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:

After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall precision biotics market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.
The precision biotics market encompasses the development, manufacturing, distribution, and commercialization of targeted microbiome-based products designed to deliver specific health benefits using scientifically validated probiotic strains and personalized formulations. Leveraging microbiome science, AI, genomics, and multi-omics technologies, these products support applications such as digestive, metabolic, immune, gut-brain, skin, women's, pediatric, and oral health.
The market is driven by the growing demand for personalized nutrition, increasing prevalence of chronic diseases, expanding microbiome research, and advancements in precision health technologies. Rising consumer awareness of preventive healthcare and the availability of clinically validated strain-specific probiotic products continue to support the global growth of the precision biotics market.
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:
Product matrix, which gives a detailed comparison of the product portfolio of each company.
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
Full forecast, segment splits, and company analysis for all Precision Biotics Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report